New preprint from our group EMBL-EBI and the TVPLab ! We combined pseudotemporal ordering of cross sectional MASLD patient data with network analysis to describe the disease progression and identify a signature of 24 plasma biomarkers for patient staging biorxiv.org/content/10.110…

👀 Not long now until the spring (25.03) Platform release… This will introduce variant, study, and credible set data, effectively merging Open Targets Genetics with the Open Targets Platform Do you have any questions or concerns that we can answer when we release?

At the first Integration Day of 2025, we were joined by Joseph Powell from the Garvan Institute and Tomas Fitzgerald from EMBL-EBI Thank you to both speakers for their time and insights on the topic of drug exposures, and for everyone who joined the day in person and online!

There are many improvements and new features in the latest Open Targets release. Genetics here we go 🚀 New data visualizations, accessible color pallets, and full UI refresh. Not to say, the addition of Observable Plot.js s, the upgrade to Vite ⚡ v6. React Router v7 🔜

Register for our webinar on 23 April! We will introduce the capabilities and use cases of the Open Targets Platform, including our new variant, study, and credible set pages released last week 👀 ebi.ac.uk/training/event…

If EMBL-EBI data resources have saved you time & effort, now is your chance to give back! Fill in a 15-minute survey to help us: 🌍Demonstrate the real-world impact of these resources 🧠Understand your needs 🌟Secure continued funding Closes 16 July 👉 surveymonkey.com/r/QGFMBH8?chan…]

Delighted to share the first preprint of my postdoc in the Carl Anderson lab medrxiv.org/content/10.110…! 🚨 A super exciting study I co-led with the very talented Tobi Alegbe. Stay tuned to discover what we learned about genetic susceptibility to complex diseases. A 🧬🧵 1/

🚨New preprint just dropped 🚨 medrxiv.org/content/10.110… The main output from my PhD is finally public and we’re SUPER excited about the findings! If you’re interested in what we learnt about IBD with a massive 700+ sample sc-eQTL dataset of the gut, read on!

Thrilled to share the latest preprint from my lab: medrxiv.org/content/10.110…. Co-led by Tobi Alegbe and Bradley Harris, supervised by myself and Tim Raine, we generated IBDverse💫 - gaining insights into genetic susceptibility and pathology of inflammatory bowel disease (IBD).